Items are required for ongoing work under the 1121 protocol.
Ended Awarded Last action
- Contract number
- HT009023FG0610010
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $11,400
Award facts
- Contract value 100% obligated
- $11,400.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
About this award
Harvard Bioscience Inc., operating through its Data Sciences International division, received a Blanket Purchase Agreement (BPA) call order valued at $11.4K from the Defense Health Agency (Military Command) on June 28, 2023, for implant exchanges required under the 1121 Protocol. This firm fixed-price task order, which was not set-aside, is scheduled for completion by September 30, 2023, with performance taking place in Mounds View, Minnesota. The award represents a continuation of Harvard Bioscience's critical role as a supplier of specialized biomedical research equipment and physiological monitoring solutions to the Department of Defense medical research community.
This call order is issued under Harvard Bioscience's existing $4.8M single-award BPA with the Defense Health Agency, which was established in May 2022 and runs through May 3, 2027. The BPA serves as an indefinite delivery vehicle enabling streamlined procurement of comprehensive biomedical research solutions, including telemetry implants, wireless transmitters, surgical supplies, and data acquisition systems for the Defense Health Agency, Army Medical Command, and other military health system partners. Task orders under this BPA have generated over $1.5M in cumulative value to date, with individual call orders typically ranging from approximately $8.3K to $235K, positioning Harvard Bioscience as a key strategic supplier for defense and military healthcare research initiatives.
Quick answers
Who was awarded contract HT009023FG0610010?
HT009023FG0610010 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on June 28, 2023.
How much is contract HT009023FG0610010 worth?
The government has obligated $11,400 on HT009023FG0610010.
Which agency awarded contract HT009023FG0610010?
Defense Health Agency (Department of Defense) awarded HT009023FG0610010, with funding from Medical Command (Department of the Army).
Is contract HT009023FG0610010 an order under another contract?
Yes. HT009023FG0610010 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT009023FG0610010 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award